The Canadian Bioceutical Corporation Converts Debt Into Equity – Baystreet.ca

The Canadian Bioceutical Corporation Converts Debt Into Equity
Baystreet.ca
In order to settle the debt BCC is issuing 3,061,947 common shares and 846,155 common share purchase warrants (each exercisable into one common share at a price of $0.275 for a one year period). Additional details of the Promissory Notes may be found …

and more

…read more

Scroll to Top